Search results
GSK was the first global healthcare company to establish a presence in Singapore in 1959. For over 60 years, GSK has been an important contributor to the healthcare system and the biopharma manufacturing sector in Singapore.
Jul 13, 2023 · THE expansion of British drugmaker GSK’s facility at Tuas has earned it the title of Singapore’s largest vaccine production site based on a cumulative investment of some S$850 million, said Minister for Trade and Industry Gan Kim Yong.
Jul 13, 2023 · SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned the title of Singapore’s largest vaccine production site based on a cumulative investment of some $850 million,...
GSK’s latest investment is a strong show of confidence in Singapore’s world-class infrastructure and skilled workforce for biopharmaceutical manufacturing. In addition to efforts in developing manufacturing leaders in Singapore, GSK has also been a steadfast partner to our research ecosystem.
May 21, 2021 · Greeting from president. 21-05-2021. I am also thankful to our devoted employees for their unwavering support. Their efficiency and readiness at addressing to the needs of our customers enable us to grow steadily. Read More.
GlaxoSmithKline (GSK) is strengthening its presence in Singapore by establishing a new global headquarters for Asia.
Nov 17, 2022 · SINGAPORE - GSK officially opened its first high-potency manufacturing and test facility in Singapore on Thursday, with the capability to manufacture highly potent components for cancer...
Jul 13, 2023 · Global biopharmaceutical powerhouse GSK is expanding its Tuas vaccines facility in Singapore and will begin producing drug substances for Hepatitis B vaccines when commercial production commences in 2027.
Oct 30, 2017 · SINGAPORE - British pharmaceutical giant GSK officially opened its Asia headquarters here on Monday (Oct 30). Called GSK Asia House, the facility in Rochester Park functions as the commercial...
Nov 18, 2022 · GSK plc today announced the opening of a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore. The opening of the facility was officiated by Guest-of-Honour, Singapore’s Minister for Health, Mr. Ong Ye Kung, and Mr. Regis Simard, GSK’s President, Global Supply Chain.
